ValiRx plc (LON:VAL – Get Free Report)’s share price traded down 1.7% during trading on Monday . The stock traded as low as GBX 0.16 and last traded at GBX 0.18. Approximately 12,977,390 shares traded hands during mid-day trading, an increase of 32% from the average session volume of 9,839,466 shares. The stock had previously closed at GBX 0.18.
ValiRx Stock Down 1.7%
The business’s 50 day moving average is GBX 0.23 and its 200 day moving average is GBX 0.30. The company has a market capitalization of £1.31 million, a price-to-earnings ratio of -0.19 and a beta of 0.59. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.27 and a current ratio of 9.66.
ValiRx (LON:VAL – Get Free Report) last released its earnings results on Monday, June 22nd. The company reported GBX (0.54) earnings per share for the quarter. ValiRx had a negative return on equity of 45.91% and a negative net margin of 3,582.56%.The company had revenue of GBX 3 million for the quarter. Sell-side analysts anticipate that ValiRx plc will post -1.74 earnings per share for the current year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
